Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
lululab is a South Korean AI beauty and health-tech company that originated as a spin-off from Samsung Electronics' C-Lab in 2017. The company specializes in artificial intelligence-driven skin analysis technology, primarily through its flagship product line, LUMINI. This platform utilizes deep learning and computer vision to scan and analyze facial skin within seconds, identifying issues such as wrinkles, pigment, redness, and pores. By leveraging a massive database of skin images, lululab provides personalized skincare recommendations and connects consumers with tailored products or clinical treatments. The company's solutions are deployed across retail, spa, and medical environments globally to enhance diagnostic accuracy in dermatology and aesthetics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on lululab.